SmarterDividends
GILD

Gilead Sciences, Inc.

GILD

Healthcare · Stock · quarterly payer

$125.59

Undervalued · +40% Add to Portfolio

Forward Yield

2.61%

Annual Dividend

$3.28

Payout Ratio

43%

5-Yr Growth

3.0%

Ex-Date

Jun 15, 2026

Frequency

Quarterly

Summary

As of June 2026, Gilead Sciences, Inc. (GILD) yields 2.61% ($3.28 per share annually), with a blended fair-value estimate of $175.25 — +40% upside, so it screens as undervalued. Dividend safety grade: A (85/100). 10 years of dividend growth.

Is GILD a good dividend stock?

Yes

Gilead Sciences, Inc. (GILD) pays a quarterly dividend yielding 2.61% ($3.28/yr), with 10 years of growth and a dividend-safety grade of A. It scores well across payout coverage, growth history and safety — a dependable income holding.

Advantages

  • 10 consecutive years of dividend growth
  • Never cut its dividend on record
  • Comfortable payout ratio (43%)
  • 82% total price return over 5 years
  • Top-tier dividend safety score

Risks

  • Single-stock concentration risk — diversify

Key Data

Dividend Yield
2.61%
Payout Ratio
43%
Annual Dividend
$3.28
5-Yr Avg Growth
3.0%
Ex-Dividend Date
Jun 15, 2026
Years of Growth
10
Frequency
quarterly
Beta
0.33
Market Cap
$155.9B
P/E Ratio
17.1
5-Yr Total Return
82%
52-Week Range
$104.46 – $157.29
Dividend Safety
A · 85/100
Ever Cut?
No
GILD ex-dividend date & scheduleNext ex-date Jun 15, 2026 · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $3.28 / yr per share

Per payment (quarterly)$82.00
Annual$328.00
Monthly avg$27.33